top of page
Nuclear Medicine Physician and Theranostics Director at Fred Hutchinson Cancer Center, Dr. Amir Iravani, shares the latest on Peptide Receptor Radionuclide Therapy (PRRT). Better understand the difference between beta and alpha PRRT, current trials and updates on PRRT for Lung NET, adolescents and dosimetry.
NET expert and radiologist Dr. Thomas Hope of UCSF addresses the latest in NET imaging and PRRT.
Nuclear Medicine Physician Dr. Erik Mittra provides an update on PRRT. Plus, hear from a NET patient who has received multiple rounds of PRRT treatments.
"Exciting Advances in NET Management: Cu64 DOTATATE & Alpha PRRT" with Ebrahim S. Delpassand, M.D., F.A.C.N.M.
Nuclear medicine specialist Dr. Delpassand provides an update on the exciting advances in NET Management including Cu64 DOTATATE & Alpha PRRT.